Clinical Evidence Supporting EU Authorisation The Marketing Authorisation of BioNet’s pertussis-only vaccine is supported by a comprehensive clinical development programme reviewed by the Committee for Medicinal Products for Human Use (CHMP). The assessment included data from three main randomised controlled clinical…